Brief: Omega Therapeutics Reports Third Quarter Financial Results
08/11/2022 12:42
Nov 8 (Reuters) - Omega Therapeutics Inc OMGA.O :
* OMEGA THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND RECENT CORPORATE HIGHLIGHTS
* QTRLY NET LOSS PER COMMON STOCK ATTRIBUTABLE TO COMMON
STOCKHOLDERS, BASIC AND DILUTED $0.54
* AS OF SEPTEMBER 30, 2022, COMPANY HAD CASH, CASH
EQUIVALENTS AND
MARKETABLE SECURITIES TOTALING $148.3 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.62 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPnc8yRdZa
Further company coverage: OMGA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence